Institute for Wealth Management LLC. Purchases 436 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Institute for Wealth Management LLC. raised its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 8,549 shares of the exchange traded fund’s stock after purchasing an additional 436 shares during the period. Institute for Wealth Management LLC.’s holdings in SPDR S&P Biotech ETF were worth $763,000 as of its most recent filing with the SEC.

Other hedge funds also recently bought and sold shares of the company. James J. Burns & Company LLC grew its stake in shares of SPDR S&P Biotech ETF by 5.0% in the third quarter. James J. Burns & Company LLC now owns 3,062 shares of the exchange traded fund’s stock valued at $224,000 after buying an additional 146 shares in the last quarter. Integrated Wealth Concepts LLC increased its stake in shares of SPDR S&P Biotech ETF by 0.7% during the 2nd quarter. Integrated Wealth Concepts LLC now owns 21,635 shares of the exchange traded fund’s stock worth $1,800,000 after purchasing an additional 155 shares during the last quarter. Ancora Advisors LLC raised its holdings in shares of SPDR S&P Biotech ETF by 47.9% in the 1st quarter. Ancora Advisors LLC now owns 491 shares of the exchange traded fund’s stock valued at $67,000 after purchasing an additional 159 shares during the period. Moser Wealth Advisors LLC raised its holdings in shares of SPDR S&P Biotech ETF by 10.4% in the 3rd quarter. Moser Wealth Advisors LLC now owns 2,041 shares of the exchange traded fund’s stock valued at $149,000 after purchasing an additional 193 shares during the period. Finally, Viewpoint Capital Management LLC lifted its stake in SPDR S&P Biotech ETF by 25.0% in the 3rd quarter. Viewpoint Capital Management LLC now owns 1,000 shares of the exchange traded fund’s stock valued at $73,000 after purchasing an additional 200 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $82.83 on Friday. The stock has a market capitalization of $6.43 billion, a P/E ratio of 11.47 and a beta of 1.08. SPDR S&P Biotech ETF has a 52 week low of $63.80 and a 52 week high of $103.52. The stock has a 50-day simple moving average of $93.52 and a 200 day simple moving average of $84.21.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.